Gastric primary non-Hodgkin lymphoma: a case report and literature review

1. Rotaru, I., Ciurea, T., Foarfa, C., Tanase, A.D. & Gaman, G. (2012). The diagnostic characteristics of a group of patients with primary gastric lymphoma: macroscopic, histopathological and immunohistochemical aspects. RJME. 53(2), 343-350Search in Google Scholar

2. D’Amore, F., Christensen, B.E., Thorling, K., Pedersen, M., Jensen, M.K., Boesen, A.M., Andersen, E., Johansen, P. & Mortensen, L.S. (1993). Incidence, presenting features and prognosis of low-grade B-cell non-Hodgkin’s lymphomas. Population base data from a Danish lymphoma registry. Leuk Lymphoma. 12(1-2), 69-77Search in Google Scholar

3. Venizelos, I., Tamiolakis, D., Bolioti, S., Nikolaidou, S., Lambropoulou, M., Alexiadis, G., Manavis, J. & Papadopoulos, N. (2005). Primary gastric Hodgkin’s lymphoma: a case report and review of the literature. Leuk Lymphoma. 46(1), 147-15010.1080/1042819040001203715621794Search in Google Scholar

4. Gurney, K.A., Cartwright, R.A. & Gilman, E.A. (1999). Descriptive epidemiology of gastrointestinal non-Hodgkin’s lymphoma in a population-based registry. Br J Cancer. 79(11-12), 1929-193410.1038/sj.bjc.6690307236278610206316Search in Google Scholar

5. Lin, P., Bueso-Ramos, C. & Wilson, C.S. et al. (2003). Waldenstrom macroglobulinemia involving extramedullary sites: Morphologic and immunophenotypic findings in 44 patients. Am J Surg Pathol. 27, 1104-111310.1097/00000478-200308000-0000712883242Search in Google Scholar

6. Alexanian, R., Weber, D. & Delasalle, K. et al. (2003). Asymptomatic Waldenstrom's macroglobulinemia. Semin Oncol. 30, 206-21010.1053/sonc.2003.5005112720137Search in Google Scholar

7. Aşchie, M. (2011). Limfoame Maligne Non- Hodgkiniene Gastrointestinale - Entitati Anatomo-Clinice si Morfologice (pp. 116-121). Bucureşti: Editura Academia de Stiinte MedicaleSearch in Google Scholar

8. Chubachi, A., Miura, A.B. & Takatsu, H. et al. (1991). Clinical significance of immunophenotype in diffuses non Hodgkin's lymphoma, with special emphasis on the clinical characteristic of T cell lymphoma, Gan To Kagaku Ryoho. 18(8), 1303-1309Search in Google Scholar

9. Biemer, J.J. (1984). Hepatic manifestations of lymphomas. Annals of Clinical and Laboratory Science. 14(4), 252-260Search in Google Scholar

10. Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., Lister, T.A. & Bloomfield, C.D. (1999). World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November 1997. J Clin Oncol. 17(12), 3835-384910.1200/JCO.1999.17.12.383510577857Search in Google Scholar

11. Ponzoni, M., Ferreri, A.J., Pruneri, G., Pozzi, B., Dell’Oro, S., Pigni, A., Pinotti, G., Villa, E., Freschi, M., Viale, G. & Capella, C. (2003). Prognostic value of bcl-6, CD10 and CD38 immunoreactivity in stage I-II gastric lymphomas: identification of a subset of CD10+ large B-cell lymphomas with a favorable outcome, Int J Cancer. 106(2), 288-29110.1002/ijc.1117912800208Search in Google Scholar

12. Conde, G.J. & Cabanillas, F. (1994). Mantie cell lymphoma, a new lymphoproliferafive entity with definite histopathological patterns, clinical characteristic and prognostic factors, and an investitional therapeutic approach. Journal of Clinical Oncology. 14 (2), 279 - 286Search in Google Scholar